drugset / Trial / NCT02884440
Transverse Abdominis Plane Block for Anterior Approach Spine Surgery
RandomizedParallel-groupTriple-blindTreatment
Summary
Therapeutic, prospective, randomized, double blind, placebo-controlled, in intention to treat, monocentric study to evaluate the analgesic efficacy of a bilateral TAP block after spine surgery with 24 hours morphine consumption
Timeline
- Start
- 2016-11-07
- Primary completion
- 2019-05-25
- Completion
- 2019-05-25
Outcome
Missed primary endpoint
paper Morphine consumption at 24 hours (28 mg [18-35] in the ropivacaine group versus 25 mg [19-37] in the placebo group [p=.503]) PMID 37031893 ↗
paper placebo group [p=.503]) were not significantly different between the two groups. PMID 37031893 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ropivacaine | Other / unclassified | 75 mg | Other |
| Background | Cisatracurium | Small molecule | 2 mg/ml | — |
| Background | Dexamethasone | Small molecule | 8 mg | — |
| Background | Ketamine | Small molecule | 0.15 mg/kg | — |
| Background | Propofol | Small molecule | 10 mg/ml | — |
| Background | Remifentanil | Small molecule | 50 ug/ml | — |